BIZENGRI

Serial Number 79396591
Registration 7830567
700

Registration Progress

Application Filed
Apr 18, 2024
Under Examination
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered
Jun 17, 2025

Trademark Image

BIZENGRI

Basic Information

Serial Number
79396591
Registration Number
7830567
Filing Date
April 18, 2024
Registration Date
June 17, 2025
Published for Opposition
April 29, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 17, 2025
Registration
Registered
Classes
001 005 042

Rights Holder

Merus N.V.

84
Address
Uppsalalaan 17,
3e en 4e verdieping NL-3584 CT Utrecht
NL

Ownership History

Merus N.V.

Original Applicant
84
NL

Merus N.V.

Owner at Publication
84
NL

Merus N.V.

Original Registrant
84
NL

Legal Representation

Attorney
Jeffrey L. Clark

USPTO Deadlines

Next Deadline
2047 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-17)
Due Date
June 17, 2031
Grace Period Ends
December 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Oct 29, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 29, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Sep 17, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 17, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 17, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 1, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 1, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 1, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 1, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 1, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 1, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 1, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 23, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 7, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 7, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 1, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Oct 31, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 1, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 30, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Biochemical products used in industry and science, namely multivalent proteins, including antibodies used in industry and science, in the fields of immuno-oncology, auto-immune, hematological and other unmet medical needs.
Class 005
Pharmaceutical and veterinary preparations prepared with multivalent proteins, including antibodies, used in industry and science, for use in the fields of immuno-oncology, and treating auto-immune disorders, hematological disorders and cancer
Class 042
Services of biochemists; services of bacteriologic and biochemical laboratories, including advice in these aspects; drawing up of professional reports by scientists, engineers, analysts and laboratory assistants and technicians, for industry and government service, in particular in the field of multivalent proteins, including antibodies, in the fields of immuno-oncology, auto-immune, hematological and other unmet medical needs; scientific and industrial research in particular in the field of the aforementioned antibodies for use in immune-oncology, auto-immune, hematological and other unmet needs; research and development of new products for third parties, in particular in the field of antibodies for use in immune-oncology, auto-immune, hematological and other unmet needs

Additional Information

Design Mark
The mark consists of the wording "BIZENGRI" in black with the first letter "I" appearing with a black base fading into green at the top and the design of a falcon with one wing in black and the other wing in green, with grey outlines on each side.
Color Claim
The color(s) black, grey and green is/are claimed as a feature of the mark.

Classification

International Classes
001 005 042